Delivery Order SPE2DB24D3013-SPE2DB25FFMHA
- Not listed
- The Defense Logistics Agency awarded a $3,694.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of BRILINTA 90 MG, an antiplatelet medication used to reduce the risk of thrombotic cardiovascular events. The award was issued on October 23, 2025, with an ultimate completion date of October 24, 2025, and represents a non-set-aside competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count units) under a firm fixed-price contract valued at $12,518.91. The order was competitively awarded without set-aside designation and is scheduled for completion by October 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,790.82 to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg, a prescription antiplatelet medication used to reduce cardiovascular events in patients with acute coronary syndrome. Issued on April 23, 2025, with an ultimate completion date of April 24, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count packages) with a contract value of $16,251.94. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on November 28, 2025, with an ultimate completion date of December 1, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,161.60 to AmerisourceBergen Drug Corp for 60 tablets of Brilinta 90 mg on December 19, 2025, with completion expected by December 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Brilinta is an antiplatelet medication commonly used in military and veteran healthcare systems to prevent...
- The Defense Logistics Agency awarded a delivery order valued at $5,028.80 to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 mg tablets (60-count package) with an ultimate completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,335.32 to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 MG tablets (60-count units). This competitively awarded, firm fixed-price delivery order was issued on June 6, 2025, with an ultimate completion date of June 9, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,307.63 to AmerisourceBergen Drug Corp for the supply of BRILINTA 90 mg tablets (60-count packages). This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by December 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will fulfill this pharmaceutical supply requirement from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,623.19 to AmerisourceBergen Drug Corp for the supply of BRILINTA 60 mg tablets (60-count package). This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is scheduled for completion by June 13, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,094.77 to AmerisourceBergen Drug Corp for 60 tablets of BRILINTA 60 mg, with a completion deadline of September 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, placed against AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFMHADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,790.13 to AmerisourceBergen Drug Corp for 60 tablets of BRILINTA 90 mg, a prescription antiplatelet medication used to reduce cardiovascular events in patients with acute coronary syndrome. The contract employs firm fixed price terms with an ultimate completion date of June 9, 2025, and carries no set-aside designation, indicating it was awarded through open competition. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as the prime vendor for comprehensive global pharmaceutical support to military healthcare programs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor. The company's substantial IDC enables it to supply a diverse range of pharmaceutical products, medical devices, vaccines, and specialty medications to support Defense Health Agency operations, the U.S. Coast Guard, and other government healthcare systems worldwide. The delivery order reflects AmerisourceBergen's ongoing role as a primary supplier within the DLA's medical supply chain, fulfilling recurring pharmaceutical needs across military and veteran healthcare systems through competitively awarded delivery orders with consistent firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 6/6/25 |